Home › Research › Tau biomarkers
CSF phospho-tau is independent of age, cognitive status and gender of neurological patients
Scheurich A, Urban PP, Koch-Khoury N, Fellgiebel A.. Journal of neurology, 2009-11-17
Topic: Brain proteins, microglia and lab models
Plain-language summary
CSF phospho-tau (p-tau(181)) levels have shown good diagnostic utility in differential diagnosis of Alzheimer disease (AD). Unlike total-tau (t-tau), age related changes of this promising biomarker are sparsely studied. The aim of the study was to determine whether p-tau(181) is dependent on age, cognitive status or gender in patients with different neurological diseases who underwent diagnostic lumbar puncture and who had no clinical evidence of neurodegenerative diseases.
What this study adds
Evidence grade: Low
In 46 neurological patients without neurodegenerative disease, spinal fluid phosphorylated tau levels did not depend on age, cognitive status or gender. This supports the marker's use in diagnosis but offers nothing for treatment or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Scheurich, A., Urban, P. P., Koch-Khoury, N., & Fellgiebel, A. (2010). CSF phospho-tau is independent of age, cognitive status and gender of neurological patients. Journal of neurology. https://doi.org/10.1007/s00415-009-5382-1
Vancouver
Scheurich A, Urban PP, Koch-Khoury N, Fellgiebel A. CSF phospho-tau is independent of age, cognitive status and gender of neurological patients. Journal of neurology. 2010. doi:10.1007/s00415-009-5382-1. PMID: 19921301.
BibTeX
@article{scheurich2010-19921301,
author = {Scheurich, A. and Urban, P. P. and Koch-Khoury, N. and Fellgiebel, A.},
title = {{CSF phospho-tau is independent of age, cognitive status and gender of neurological patients}},
journal = {Journal of neurology},
year = {2010},
doi = {10.1007/s00415-009-5382-1},
pmid = {19921301},
url = {https://doi.org/10.1007/s00415-009-5382-1}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Unlike total-tau (t-tau), age related changes of this promising biomarker are sparsely studied.
- The aim of the study was to determine whether p-tau(181) is dependent on age, cognitive status or gender in patients with different neurological diseases who underwent diagnostic lumbar puncture and who had no clinical evidence of neurodegenerative diseases.
- CSF levels of p-tau(181) and total-tau (t-tau) of 46 neurologic patients (age range 22-89 years; 22 male, 24 female) were analyzed.
- Clinical diagnoses were cerebral ischaemia (n = 6), multiple sclerosis (n = 13), epileptic seizures (n = 3), polyneuropathy (n = 9) and other neurological diagnoses (n = 15).
Why it matters
In 46 neurological patients without neurodegenerative disease, spinal fluid phosphorylated tau levels did not depend on age, cognitive status or gender. This supports the marker's use in diagnosis but offers nothing for treatment or prevention.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthLow
How this study scored 33/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of neurology) |
| Journal's citation record | 2 / 4 | Journal of Neurology: journal h-index 208 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2010 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 15 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.8 citations a year over 18 year(s) since 2010 |
| Impact for its field and year | 2 / 6 | Cited 1.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Andreas Fellgiebel: h-index 49 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Johannes Gutenberg University Mainz: institution h-index 934 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 19921301) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 33 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Tau biomarkers from nearby years
Also tagged “phosphorylated”
733 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 733 tagged studies.